Drug Prices
Commentary
Learn why drug price controls don't work
The Expected Consequences Of Price Controls
The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
Commentary
Learn why drug price controls don't work
Don’t Buy Kamala Harris’ Anti-Price Gouging Plan
That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
Commentary
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Commentary
Read the latest about the problems with PBMs
Insulin Lawsuits Obscure A Dirty Business
The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
Commentary
Read the latest about VP Harris' healthcare platform
Harris commits to worst of Biden healthcare policies
One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
Blog
Read about Biden drug price control plan
The Damage from Price Controls on Pharmaceuticals Begins
The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
Biosimilars
NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Blog
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Commentary
Read latest about push for drug price controls
U.S. consumers shouldn’t be seduced by drug importation dreams and promises
Republicans, meanwhile, are embracing the price controls that foreign countries impose on prescription drugs. Texas recently enacted a law seeking approval from the Biden administration to import cheaper prescription drugs from Canada, my native land. Texas now joins Republican-led Florida and New Hampshire in pressing for a way to import ...
Commentary
Seniors are disappointed with efforts to lower Medicare costs — and rightly so
But wait, the law’s proponents may say: The federal government hasn’t yet exercised its power to “negotiate” — or more accurately, cap — the prices of drugs in Medicare. Those price controls may save the federal government money. But patients won’t see much of the savings. The federal government has ...
Learn why drug price controls don't work
The Expected Consequences Of Price Controls
The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
Learn why drug price controls don't work
Don’t Buy Kamala Harris’ Anti-Price Gouging Plan
That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Read the latest about the problems with PBMs
Insulin Lawsuits Obscure A Dirty Business
The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
Read the latest about VP Harris' healthcare platform
Harris commits to worst of Biden healthcare policies
One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
Read about Biden drug price control plan
The Damage from Price Controls on Pharmaceuticals Begins
The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
NEW ISSUE BRIEF: Biosimilar Competition Lowers Patient Drug Costs, New Competition Will Bring Even More Savings
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute provides the latest evidence that biosimilar competition is saving patients billions – and additional competition would increase savings even more. Click to download the brief From 2019-2023, patients saved $15 billion ...
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Read latest about push for drug price controls
U.S. consumers shouldn’t be seduced by drug importation dreams and promises
Republicans, meanwhile, are embracing the price controls that foreign countries impose on prescription drugs. Texas recently enacted a law seeking approval from the Biden administration to import cheaper prescription drugs from Canada, my native land. Texas now joins Republican-led Florida and New Hampshire in pressing for a way to import ...
Seniors are disappointed with efforts to lower Medicare costs — and rightly so
But wait, the law’s proponents may say: The federal government hasn’t yet exercised its power to “negotiate” — or more accurately, cap — the prices of drugs in Medicare. Those price controls may save the federal government money. But patients won’t see much of the savings. The federal government has ...
